In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine.
Cephradine was microencapsulated by coacervation. Ethyl cellulose was used as the polymer and a core/wall ratio of 1:1 was selected. The repose angle, apparent and tapped density, particle size distribution of cephradine microcapsules (CM) and of cephradine powder were examined. Then flat-surfaced tablets of CM were prepared using Avicel PH 101 and magnesium stearate. In vitro and in vivo properties of CM and tabletted CM (both equivalent to 150 mg cephradine) were compared with commercial capsules (equivalent to 250 mg cephradine). The dissolution studies were carried out by the rotating basket method and the agar diffusion method was applied for quantitative determinations. Among the investigated kinetic models for the release of cephradine from CM and tabletted CM the best fit was found with the Higuchi model. In vivo studies were made in rabbits. Bioavailabilities of CM and their tabletted form were higher than that of the commercial capsules. In vitro/in vivo correlations between mean residence time (MRT) and mean dissolution time (MDT) for CM and tabletted CM were calculated. A good correlation was found between the in vitro and in vivo results.
Tuncel
T
T
Department of Pharmaceutical Technology, University of Istanbul, Turkey.
Bergsadi
N
N
Akin
L
L
Otük
G
G
Kuşçu
I
I
D000818:Animals; D001682:Biological Availability; D002214:Capsules; D002511:Cephalosporins / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D002515:Cephradine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D007700:Kinetics; D008826:Microbial Sensitivity Tests; D010316:Particle Size; D011208:Powders; D011817:Rabbits; D013211:Staphylococcus aureus / Q000187:drug effects; D013607:Tablets
D002214:Capsules; D002511:Cephalosporins; D011208:Powders; D013607:Tablets; D002515:Cephradine